Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 15:772:34-41.
doi: 10.1016/j.mrgentox.2014.07.010. Epub 2014 Aug 7.

Single cell gel electrophoresis (SCGE) and Pig-a mutation assay in vivo-tools for genotoxicity testing from a regulatory perspective: a study of benzo[a]pyrene in Ogg1(-/-) mice

Affiliations

Single cell gel electrophoresis (SCGE) and Pig-a mutation assay in vivo-tools for genotoxicity testing from a regulatory perspective: a study of benzo[a]pyrene in Ogg1(-/-) mice

Anne Graupner et al. Mutat Res Genet Toxicol Environ Mutagen. .

Abstract

The OECD has developed test guidelines (TG) to identify agents with genotoxic effects. The in vivo alkaline single cell gel electrophoresis (SCGE) assay is currently being prepared to become such a TG. The performance of a combined SCGE/Pig-a gene mutation study was evaluated with the prototypical genotoxicant benzo[a]pyrene (BaP) at an exposure level known to induce germ cell mutation. We aimed to better understand (i) the strengths and weaknesses of the two methods applied in blood and their potential to predict germ cell mutagenicity, and (ii) the involvement of reactive oxygen species (ROS) following in vivo BaP-exposure. To explore the involvement of ROS on BaP genotoxicity, we utilised a mouse model deficient in a DNA glycosylase. Specifically, C57BL/6 mice (Ogg1(+/+) and Ogg1(-/-)) were treated for three consecutive days with 50 mg BaP/kg/day. DNA damage in nucleated blood cells was measured four hours after the last treatment with the SCGE assay, with and without formamidopyrimidine DNA glycosylase (Fpg). Pig-a mutant phenotype blood erythrocytes were analysed two and four weeks after treatment. BaP-induced DNA lesions were not significantly increased in either version of the SCGE assay. The phenotypic mutation frequencies for immature and mature erythrocytes were significantly increased after two weeks. These effects were not affected by genotype, suggesting oxidative damage may have a minor role in BaP genotoxicity, at least in the acute exposure situation studied here. While both assays are promising tools for risk assessment, these results highlight the necessity of understanding the limitations regarding each assay's ability to detect chemicals' genotoxic potential.

Keywords: Alkaline single cell gel electrophoresis (SCGE); Benzo[a]pyrene (BaP); Genotoxicity; Hazard identification; Pig-a mutation assay; Risk assessment.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Metabolism of Benzo[a]pyrene (BaP)
The metabolism primarily occurs via cytochrome P450s (CYP1A1 and CYP1B1), peroxidases (epoxide hydrolase) and aldo-keto reductase. The major metabolite which is thought to cause carcinogenesis is BaP-7,8-diol-9,10-epoxide (BPDE) which is metabolised via BaP-7,8-epoxide and BaP-7,8-diol. BPDE forms DNA-adducts which can induce G→T transversions. In addition, many metabolites (such as catechol and dione within a futile cycle) form reactive oxygen species (ROS) thus adding to oxidative stress and contributing to the formation of oxidative DNA lesions such as 8-oxoguanine, a pre-mutagenic DNA lesion. Radical cations are formed in a minor quantity.
Figure 2
Figure 2. Study design
Eight C57BL/6 mice of two different genotypes (Ogg1+/+ and Ogg1−/−) were treated with BaP on three consecutive days (total of 150 mg/kg bw, ip). In addition, three mice of each genotype were injected with corn oil as vehicel control. Blood for the Pig-a mutation assay was drawn one week prior BaP-treatment (day −5), and two weeks (day 16) and four weeks (day 34) after the last chemical treatment. Blood for the SCGE was drawn four hours after the last injections of BaP or vehicle control.
Figure 3
Figure 3. DNA lesions in mouse blood cells measured by the alkaline SCGE without (A) and with Fpg (B) four hours after treatment with BaP
Each circle represents data for one mouse as mean (n = 8 for BaP, n = 3 for corn oil), based on three technical replicates per mouse. Mouse genotypes and treatments are indicated on the horizontal axis. The box plot shows the median and the first and third quartile.
Figure 4
Figure 4. Pig-a mutant frequencies and percent reticulocytes in blood cells of mice treated with BaP
Data is given as median (SD) for the percentage of reticulocytes (A), and the mutation frequencies of red blood cells (B) and reticulocytes (C). Data was compared to each other by Dunnett’s multiple comparison within a one way ANOVA. Significant differences to the vehicle control (corn oil) of the same genotype and sampling day are indicated by asterisks: p ≤ 0.05 (*) and p ≤ 0.001 (**). Significant differences between day 16 and day 34, respectively, to day −5 are marked with crosses: p ≤ 0.05 (+) and p ≤ 0.001 (++).

Similar articles

Cited by

References

    1. Kirkland D, Speit G. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. Mutat Res. 2008;654:114–132. - PubMed
    1. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–191. - PubMed
    1. Boiteux S, Gajewski E, Laval J, Dizdaroglu M. Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. Biochemistry. 1992;31:106–110. - PubMed
    1. Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S. 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci U S A. 1991;88:4690–4694. - PMC - PubMed
    1. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environmental and molecular mutagenesis. 2010;51:825–835. - PubMed

Publication types